Osteochondral angiogenesis and increased protease inhibitor expression in OA
Open Access
- 30 April 2010
- journal article
- Published by Elsevier BV in Osteoarthritis and Cartilage
- Vol. 18 (4), 563-571
- https://doi.org/10.1016/j.joca.2009.11.015
Abstract
No abstract availableKeywords
Funding Information
- AstraZeneca (14851)
This publication has 37 references indexed in Scilit:
- Neurovascular invasion at the osteochondral junction and in osteophytes in osteoarthritisAnnals Of The Rheumatic Diseases, 2007
- The secretory leukocyte protease inhibitor (SLPI) suppresses cancer cell invasion but promotes blood‐borne metastasis via an invasion‐independent pathwayThe Journal of Pathology, 2007
- Post-mortem collection of human joint tissues for researchRheumatology, 2003
- Development and regulation of osteophyte formation during experimental osteoarthritisOsteoarthritis and Cartilage, 2002
- Secretory leucocyte proteinase inhibitor is produced by human articular cartilage chondrocytes and intervertebral disc fibrochondrocytesJBIC Journal of Biological Inorganic Chemistry, 1993
- Cartilage synthesizes the serine protease inhibitor PAI-1: Support for the involvement of serine proteases in cartilage remodelingJournal of Orthopaedic Research, 1991
- Identification of an Inhibitor of Neovascularization from CartilageScience, 1990
- Neovascularisation and its role in the osteoarthritic process.Annals Of The Rheumatic Diseases, 1988
- Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the kneeArthritis & Rheumatism, 1986
- The pathogenesis of osteoarthrosisMedical Hypotheses, 1979